A radiocephalic arteriovenous fistula (AVF) is the best choice for achieving vascular access (VA) for hemodialysis, but this AVF has high rates of early failure due to juxta-anastomotic stenosis, making it impossible to use for dialysis. Low hemodynamic shear stress contributes to the pathophysiology of VA failure due to secondary thrombosis, stenosis, and re-occlusion after percutaneous intervention. We used a computational fluid dynamics (CFDs) approach to evaluate the shear stress distribution and minimize its effects under various conditions including changes in the anastomosis angle. A three-dimensional computational domain was designed for arteriovenous end-to-side anastomosis based on anastomosis angles of 45°, 90° and including 135° angle of an obtuse anastomosis using three-dimensional design software. COMSOL Multiphysics® simulation software was used to identify the hemodynamic factors influencing wall shear stress at the anastomosis site using a low Reynolds number k-ε turbulence model that included non-Newtonian blood flow characteristics, the complete cardiac pulse cycle, and distention of blood vessels. In preliminary clinical study, all 201 patients who received a radiocephalic wrist AVF from January 2009 to February 2014 were divided into classic and obtuse angle groups. The CFD results showed that the largest anastomosis angle (135°) resulted in lower shear stress, which would help reduce AVF failures. This obtuse angle was preferred, as it minimized the development of anastomotic stenosis and tended to favor primary and primary-assisted patency in clinical study. An obtuse radiocephalic wrist AVF shows more favorable patency compared to a classic radiocephalic AVF. Surgeons establishing a radiocephalic wrist AVF would be better to consider an AVF with an obtuse anastomosis.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]